Riluzole in generalized anxiety disorder: An open-label trial

被引：0
|
作者：
Amiel, JM
Mathew, SJ
Coplan, JD
Fitterling, HA
Sackeim, HA
Gorman, JM
机构：
[1] New York State Psychiat Inst & Hosp, Dept Biol Psychiat, New York, NY 10032 USA
[2] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY USA
[3] Columbia Univ, Coll Phys & Surg, Dept Radiol, New York, NY USA
[4] Downstate Med Ctr, Dept Psychiat, Brooklyn, NY USA
[5] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA
[6] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA
来源：
DEPRESSION AND ANXIETY | 2005年 / 22卷 / 04期
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [1] Riluzole in generalized anxiety disorder: An open-label trial
    Mathew, SJ
    Amiel, JM
    Coplan, JD
    Fitterling, HA
    Sackeim, HA
    Gorman, JM
    [J]. NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S154 - S154
  • [2] Open-label trial of riluzole in generalized anxiety disorder
    Mathew, SJ
    Amiel, JM
    Coplan, JD
    Fitterling, HA
    Sackeim, HA
    Gorman, JM
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (12): : 2379 - 2381
  • [3] An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder
    Menza, Matthew A.
    Dobkin, Roseanne D.
    Marin, Humberto
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (02) : 207 - 210
  • [4] An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder
    Kaplan, Alicia
    Franzen, Michael D.
    Nickell, P. V.
    Ransom, Danielle
    Lebovitz, Paul J.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2014, 18 (01) : 11 - 15
  • [5] Open-label pilot study of ziprasidone for refractory generalized anxiety disorder
    Snyderman, SH
    Rynn, MA
    Rickels, K
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 497 - 499
  • [6] Tiagabine for the treatment of generalized anxiety disorder: A randomized, open-label, clinical trial with paroxetine as a positive control
    Rosenthal, M
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2003, 64 (10) : 1245 - 1249
  • [7] An open-label trial of escitalopram in children and adolescents with social anxiety disorder
    Isolan, Luciano
    Pheula, Gabriel
    Salum, Giovanni Abrahao, Jr.
    Oswald, Sylvia
    Rohde, Luis Augusto
    Manfro, Gisele Gus
    [J]. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2007, 17 (06) : 751 - 759
  • [8] Differential Efficacy of Memantine for Obsessive-Compulsive Disorder vs. Generalized Anxiety Disorder: An Open-Label Trial
    Feusner, Jamie D.
    Kerwin, Lauren
    Saxena, Sanjaya
    Bystritsky, Alexander
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 2009, 42 (01) : 81 - 93
  • [9] Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial
    Coric, V
    Taskiran, S
    Pittenger, C
    Wasylink, S
    Mathalon, DH
    Valentine, G
    Saksa, J
    Wu, YT
    Gueorguieva, R
    Sanacora, R
    Malison, RT
    Krystal, JH
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 58 (05) : 424 - 428
  • [10] Efficacy of quetiapine in generalized social anxiety disorder: Results from an open-label study
    Schutters, SJ
    van Megen, HJGM
    Westenberg, HGM
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (04) : 540 - 542
12345